Two studies led by the Garvan Institute of Medical Research have revealed that nitrogen-bisphosphonates, drugs commonly prescribed for osteoporosis, reduced the risk of premature mortality by 34% in a cohort of over 6,000 ...
Aug 12, 2019
0
6
People who have had a stroke, and the doctors who treat them, have a lot to be concerned about: regaining mobility and function, controlling risk factors for a second stroke, guarding against depression that can result from ...
Aug 9, 2019
0
2
A new study from the University of Bristol has linked bone strength to the timing of puberty.
Aug 9, 2019
0
120
(HealthDay)—Osteoporosis is common in patients undergoing total joint arthroplasty (TJA), yet the condition is often undertreated, according to a study published in the July issue of the Journal of Arthroplasty.
Jul 10, 2019
0
1
(HealthDay)—Cerebral palsy (CP) is associated with an increased risk for osteoporosis and osteoarthritis, according to a study published in the August issue of Bone.
Jul 9, 2019
0
0
The impact of interruption of anti-osteoporosis treatment in patients on therapy with bisphosphonates or denosumab is reviewed in a new International Osteoporosis Foundation (IOF) working group paper 'Fracture risk following ...
Jul 8, 2019
0
1
Dear Mayo Clinic: I've never had a fracture or bone health issues. Should I still get a bone density test?
Jul 5, 2019
0
1
There are a few household products we use everyday, but they could increase your osteoporosis risk, according to a new report.
Jul 3, 2019
1
5
New University of Minnesota Medical School research evaluates the impact of multimorbidity on the probability of hip fractures.
Jun 28, 2019
0
0
Sclerostin is a protein produced by osteocytes in the bone that inhibits bone formation. A recent analysis of results from a clinical trial reveals the beneficial effects of romosozumab, an antibody therapy that targets sclerostin, ...
Jun 25, 2019
0
4
